Thomas G. Hartung - Toxicology

Author Information

Thomas Hartung is a distinguished researcher in the field of toxicology, currently affiliated with the Center for Alternatives to Animal Testing at the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, USA. He also holds a position in the Department of Pharmacology and Toxicology at the University of Konstanz in Germany. His work primarily focuses on advancing methods that reduce the use of animals in scientific research and exploring innovative approaches to toxicology.

Research Contributions

Thomas Hartung has made significant contributions to the field of toxicology, with a particular emphasis on developing safer chemical testing methods that minimize animal use. His recent work includes leading initiatives such as the European ONTOX project, which aims to enhance chemical safety through innovative toxicological approaches. He has also contributed to the understanding of chemical hazard predictions, developmental neurotoxicity, and the application of microphysiological systems, especially in the context of COVID-19 research. Hartung's research efforts are pivotal in promoting sustainable chemistry and avoiding regrettable substitutions in chemical development.

Aliases

Thomas Hartung is also known by several aliases, including T. Hartung, Thomas G. Hartung, Th. Hartung, and T Hartung. These variations are used across different publications and platforms.

Publication and Citation Metrics

Metric	Value
Total Papers	675
Total Citations	33,272
h-index	95

Publications:

Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)

DOI: 10.1007/s11306-021-01848-6

Year: 2022

Safer chemicals using less animals: kick-off of the European ONTOX project.

DOI: 10.1016/j.tox.2021.152846

Year: 2021

The state of the scientific revolution in toxicology.

DOI: 10.14573/altex.2106101

Year: 2021

A Systematic Review to Compare Chemical Hazard Predictions of the Zebrafish Embryotoxicity Test With Mammalian Prenatal Developmental Toxicity

DOI: 10.1093/toxsci/kfab072

Year: 2021

Similarities and Differences in Gene Expression Networks Between the Breast Cancer Cell Line Michigan Cancer Foundation-7 and Invasive Human Breast Cancer Tissues

DOI: 10.3389/frai.2021.674370

Year: 2021

Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity

DOI: 10.3390/ijms22157929

Year: 2021

Evidence Integration in the Era of Information Flooding—The Advent of the Comprehensive Review

DOI: 10.3389/fpubh.2021.763828

Year: 2021

Avoiding Regrettable Substitutions: Green Toxicology for Sustainable Chemistry

DOI: 10.1021/ACSSUSCHEMENG.0C09435

Year: 2021

COVID-19 - prime time for microphysiological systems, as illustrated for the brain.

DOI: 10.14573/altex.2110131

Year: 2021

Continuing Animal Tests on Cosmetic Ingredients for REACH in the EU.

DOI: 10.14573/altex.2104221

Year: 2021

How Should Chemicals be Handled Safely?

What are the Clinical Implications of Low Osmolarity?

Is Chicle Regulated?

Can Enzymatic Cleaners Cause Allergic Reactions?

How Is Data Used in Risk Assessment?

What Are the Key Programs Conducted by the EPA?

Can Nutritional Supplements Be Toxic?

How is Coal Tar Used?

What is Tubulin?

How Does FISH Compare to Other Techniques in Toxicology?

Partnered Content Networks

Relevant Topics